Downloads: 61
Case Studies | Medical Science | Volume 10 Issue 3, March 2021 | Pages: 308 - 311 | Indonesia
Intravenous Immunoglobulin as a Therapeutic Option in Severe COVID-19 Patient: Case Report
Abstract: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for the ongoing pandemic of coronavirus disease 2019 (COVID-19). Until now, no definite effective treatment has been identified. Case Report: This article reports a 41 year old male, diagnosed with Confirmed Pneumonia COVID-19 with hypertension, transaminitis and obesity. The patient received high-dose intravenous immunoglobulin (IVIg) therapy. Conclusion: Patient was treated by intravenous immunoglobulin (IVIg) showed satisfactory recovery. Based on observations, IVIg should be considered in deteriorating patients infected with COVID-19. However further investigations are needed to explain this further.
Keywords: COVID-19, IVIg
How to Cite?: Yulia Karolina Kurniawati, Ongky Aristian, Anak Agung Gde Upeksha, "Intravenous Immunoglobulin as a Therapeutic Option in Severe COVID-19 Patient: Case Report", Volume 10 Issue 3, March 2021, International Journal of Science and Research (IJSR), Pages: 308-311, https://www.ijsr.net/getabstract.php?paperid=SR21301132041, DOI: https://dx.doi.org/10.21275/SR21301132041